Kiora Pharmaceuticals
KPRX
5 hedge funds and large institutions have $987K invested in Kiora Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
7% less capital invested
Capital invested by funds: $1.06M → $987K (-$74K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$32.2K |
| 2 |
Morgan Stanley
New York
|
+$16.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$48.4K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$28K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$16.1K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $624K | -$48.4K | -3 | -7% |
|
|
AIC
2
AWM Investment Company
New York
| $292K | – | – | – |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $35K | +$32.2K | +2 | New |
|
|
VIA
4
Vantage Investment Advisors
State College,
Pennsylvania
| $18K | – | – | – |
|
|
5
Morgan Stanley
New York
| $14K | +$16.1K | +1 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $4K | -$16.1K | -1 | Closed |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| – | -$28K | -2 | Closed |
|
|
8
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$1K | – | – |
|
KPRX Hedge Fund Activity: Q4 2015 in Review
5 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Kiora Pharmaceuticals (KPRX) for Q4 2015, worth a combined $987K — down 7% from $1.06M a quarter earlier.
Fund positioning in KPRX was balanced in Q4 2015: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $32.2K. The largest seller was Sabby Management, cutting an estimated $48.4K.
- 5 institutional investors held Kiora Pharmaceuticals (KPRX) as of Q4 2015, unchanged from Q3 2015.
- Funds reported $987K of Kiora Pharmaceuticals stock for Q4 2015, down 7% quarter-over-quarter.
- 2 funds opened new Kiora Pharmaceuticals positions in Q4 2015 and 2 closed out, a net change of 0 holders.
- The largest Kiora Pharmaceuticals buyer in Q4 2015 was Vanguard Group, an estimated $32.2K added.
- The largest Kiora Pharmaceuticals seller in Q4 2015 was Sabby Management, an estimated $48.4K sold.
Based on aggregated 13F filings for Q4 2015.